LivaNova PLC (LIVN) has a MoatMap StockRank of 87/100 based on Quality (60/100), Value (38/100), and Momentum (75/100) factor scores. The current signal is STRONG BUY. LivaNova is a medical technology company focused on neuromodulation and cardiopulmonary devices. It operates in highly regulated markets but lacks the explosive growth, pricing power, or thematic velocity required for our high-conviction portfolio.
LivaNova PLC is a global medical technology company dedicated to developing innovative solutions for cardiovascular and neuromodulation therapies, including heart-lung machines and vagus nerve stimulation (VNS) for epilepsy and depression. The company maintains a competitive moat through its proprietary technologies, extensive R&D, and strong intellectual property in highly specialized and regulated medical device markets.
| Price | $77.17 |
| Market Cap | $4.0B |
| P/E (TTM) | 37.61 |
| P/E (Forward) | 15.92 |
| Price/Book | 3.34 |
| Return on Equity | 9.5% |
| Return on Invested Capital | -9.5% |
| Debt/Equity | 28.35 |
| Gross Margin | 67.9% |
| Operating Margin | 14.4% |
| Revenue Growth | 14.3% |
| Free Cash Flow | $198M |
LivaNova PLC operates in the Medical Devices industry, part of the Healthcare sector (United Kingdom).